MACKENZIE FINANCIAL CORP - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$91,656
+6.9%
21,119
-24.9%
0.00%
Q2 2023$85,723
+119.4%
28,1060.0%0.00%
Q1 2023$39,067
-30.2%
28,1060.0%0.00%
Q4 2022$55,931
-91.0%
28,106
-84.2%
0.00%
-100.0%
Q1 2020$619,000177,8780.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders